India
# |
Name |
Dividend Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 4.53
|
Dec. 31, 2023 | USD 61.92 | -0.63% |
|
India |
|
2 |
USD 3.90
|
March 31, 2024 | USD 339.25 | -0.02% |
|
India |
|
3 |
USD 3.00
|
June 30, 2024 | USD 60.92 | -1.55% |
|
India |
|
4 |
USD 0.48
|
March 31, 2024 | USD 48.55 | -2.16% |
|
India |
|
5 |
USD 0.38
|
March 31, 2024 | USD 24.47 | -2.67% |
|
India |
|
6 |
USD 0.36
|
March 31, 2024 | USD 36.49 | -1.65% |
|
India |
|
7 |
USD 0.22
|
March 31, 2024 | USD 8.89 | -0.43% |
|
India |
|
8 |
USD 0.19
|
March 31, 2024 | USD 86.25 | -0.49% |
|
India |
|
9 |
USD 0.12
|
March 31, 2024 | USD 19.18 | 0.81% |
|
India |
|
10 |
USD 0.12
|
March 31, 2024 | USD 167.70 | 3.37% |
|
India |
|
11 |
USD 0.11
|
March 31, 2024 | USD 14.65 | -2.48% |
|
India |
|
12 |
USD 0.10
|
March 31, 2024 | USD 16.67 | -0.55% |
|
India |
|
13 |
USD 0.10
|
March 31, 2024 | USD 10.15 | 0.53% |
|
India |
|
14 |
USD 0.10
|
March 31, 2024 | USD 13.95 | -1.21% |
|
India |
|
15 |
USD 0.08
|
March 31, 2024 | USD 25.55 | -4.35% |
|
India |
|
16 |
USD 0.07
|
March 31, 2024 | USD 11.02 | -2.61% |
|
India |
|
17 |
USD 0.06
|
March 31, 2024 | USD 11.42 | 0.31% |
|
India |
|
18 |
USD 0.06
|
March 31, 2024 | USD 4.33 | -0.95% |
|
India |
|
19 |
USD 0.06
|
March 31, 2024 | USD 2.77 | -8.82% |
|
India |
|
20 |
USD 0.05
|
March 31, 2024 | USD 13.45 | -0.86% |
|
India |
|
21 |
USD 0.05
|
March 31, 2024 | USD 17.27 | -1.52% |
|
India |
|
22 |
USD 0.05
|
March 31, 2024 | USD 24.79 | -1.08% |
|
India |
|
23 |
USD 0.05
|
March 31, 2024 | USD 20.54 | -1.93% |
|
India |
|
24 |
USD 0.04
|
March 31, 2024 | USD 2.04 | -1.99% |
|
India |
|
25 |
USD 0.02
|
March 31, 2024 | USD 16.55 | -3.58% |
|
India |
|
26 |
USD 0.02
|
March 31, 2024 | USD 12.17 | 3.64% |
|
India |
|
27 |
USD 0.02
|
March 31, 2024 | USD 17.25 | -19.71% |
|
India |
|
28 |
USD 0.02
|
March 31, 2024 | USD 4.31 | -2.14% |
|
India |
|
29 |
USD 0.02
|
March 31, 2024 | USD 7.16 | -1.98% |
|
India |
|
30 |
USD 0.02
|
March 31, 2024 | USD 14.23 | -0.83% |
|
India |
|
31 |
USD 0.02
|
March 31, 2024 | USD 6.50 | -2.02% |
|
India |
|
32 |
USD 0.02
|
March 31, 2024 | USD 8.39 | -1.57% |
|
India |
|
33 |
USD 0.02
|
March 31, 2024 | USD 8.42 | -0.78% |
|
India |
|
34 |
USD 0.01
|
March 31, 2024 | USD 1.20 | -5.08% |
|
India |
|
35 |
USD 0.01
|
March 31, 2024 | USD 4.63 | -2.34% |
|
India |
|
36 |
USD 0.01
|
March 31, 2024 | USD 7.13 | -4.42% |
|
India |
|
37 |
USD 0.01
|
March 31, 2024 | USD 8.27 | -6.12% |
|
India |
|
38 |
USD 0.01
|
March 31, 2024 | USD 1.71 | 0.29% |
|
India |
|
39 |
USD 0.01
|
March 31, 2024 | USD 2.52 | -4.77% |
|
India |
|
40 |
USD 0.01
|
March 31, 2024 | USD 3.05 | -1.72% |
|
India |
|
41 |
USD 0.00
|
March 31, 2024 | USD 2.41 | -2.63% |
|
India |
|
42 |
USD 0.00
|
March 31, 2024 | USD 4.72 | -1.03% |
|
India |
|
43 |
USD 0.00
|
March 31, 2024 | USD 1.19 | -2.10% |
|
India |
|
44 |
USD 0.00
|
March 31, 2024 | USD 5.26 | -2.10% |
|
India |
|
45 |
USD 0.00
|
March 31, 2024 | USD 0.13 | -0.49% |
|
India |
|
46 |
USD -0.00
|
March 31, 2024 | USD 0.17 | -3.99% |
|
India |
|
47 |
USD -0.00
|
March 31, 2024 | USD 1.12 | -4.46% |
|
India |
|
48 |
USD -0.00
|
March 31, 2024 | USD 2.98 | -4.89% |
|
India |
|
49 |
USD -0.00
|
March 31, 2024 | USD 1.79 | -0.60% |
|
India |
|
50 |
USD -0.00
|
March 31, 2024 | USD 16.89 | -2.20% |
|
India |
The Clinical Trials company in India with the highest Dividend Per Share is Sanofi India Limited (NSE: SANOFI.NS) at USD 4.53.
The Clinical Trials company in India with the lowest Dividend Per Share is Panacea Biotec Limited (NSE: PANACEABIO.NS) at USD -0.00.
The top 10 Clinical Trials companies in India by Dividend Per Share are Sanofi India Limited, Abbott India Limited, Procter & Gamble Health Limited, Pfizer Limited, GlaxoSmithKline Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Thyrocare Technologies Limited, AstraZeneca Pharma India Limited, J. B. Chemicals & Pharmaceuticals Limited and Neuland Laboratories Limited.
The bottom 10 Clinical Trials companies in India by Dividend Per Share are Panacea Biotec Limited, Orchid Pharma Limited, Innova Captab Limited, Kilitch Drugs (India) Limited, Nectar Lifesciences Limited, Krebs Biochemicals & Industries Limited, Lyka Labs Limited, Medico Remedies Limited, Mankind Pharma Limited and Indegene Limited.